Vitamin D deficiency and prognostics among patients with pancreatic adenocarcinoma

Journal of Translational Medicine

Volumn 11, Issue 1, 2013, Pages

  Cho, May ^a   Peddi, Parvin F ^b,d   Ding, Kevin ^c   Chen, Ling ^a   Thomas, Denise ^a,b   Wang, Jian ^e   Lockhart, Albert C ^a,b   Tan, Benjamin ^a,b   Wang Gillam, Andrea ^a,b  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SAINT LOUIS UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e ZHENGZHOU UNIVERSITY   (China)

Author keywords

Pancreatic cancer; Prognostic factors; Vitamin D; Vitamin D receptor

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D; 25-HYDROXYVITAMIN D;

ADULT; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; DEMOGRAPHY; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL DEFICIENCY; NUTRITIONAL STATUS; PANCREAS ADENOCARCINOMA; PREVALENCE; RETROSPECTIVE STUDY; UNITED STATES; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D INSUFFICIENCY; ADENOCARCINOMA; ANALOGS AND DERIVATIVES; BLOOD; COMPLICATION; KAPLAN MEIER METHOD; MIDDLE AGED; MULTIVARIATE ANALYSIS; PANCREAS TUMOR; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

ADENOCARCINOMA; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84883509784     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-206     Document Type: Article

References (27)

1. American Cancer Society Facts and Figures 2013,
2. Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 2005, 16:83-95. 10.1007/s10552-004-1661-4, 15868450.
3. Holick MF. Vitamin D deficiency. N Engl J Med 2007, 357:266-81. 10.1056/NEJMra070553, 17634462.
4. Garland CF, Gorham ED, Mohr SB, et al. Vitamin D for cancer prevention: global perspective. Ann Epidemiol 2009, 19:468-83. 10.1016/j.annepidem.2009.03.021, 19523595.
5. Gorham ED, Garland CF, Garland FC, et al. Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med 2007, 32:210-6. 10.1016/j.amepre.2006.11.004, 17296473.
6. Stolzenberg-Solomon RZ, Jacobs EJ, Arslan AA, et al. Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 2010, 172:81-93. 10.1093/aje/kwq120, 2892543, 20562185.
7. Wolpin BM, Ng K, Bao Y, et al. Plasma 25-hydroxyvitamin D and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2012, 21:82-91. 10.1158/1055-9965.EPI-11-0836, 3253914, 22086883.
8. Anderson LN, Cotterchio M, Knight JA, et al. Genetic variants in vitamin d pathway genes and risk of pancreas cancer; results from a population-based case-control study in ontario, Canada. PLoS One 2013, 8:e66768. 10.1371/journal.pone.0066768, 3691295, 23826131.
9. Ren C, Qiu MZ, Wang DS, et al. Prognostic effects of 25-hydroxyvitamin D levels in gastric cancer. J Transl Med 2012, 10:16. 10.1186/1479-5876-10-16, 3295723, 22284859.
10. Ng K, Meyerhardt JA, Wu K, et al. Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol 2008, 26:2984-91. 10.1200/JCO.2007.15.1027, 18565885.
11. Tretli S, Hernes E, Berg JP, et al. Association between serum 25(OH)D and death from prostate cancer. Br J Cancer 2009, 100:450-4. 10.1038/sj.bjc.6604865, 2658536, 19156140.
12. Drake MT, Maurer MJ, Link BK, et al. Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma. J Clin Oncol 2010, 28:4191-8. 10.1200/JCO.2010.28.6674, 2953973, 20713849.
13. Tretli S, Schwartz GG, Torjesen PA, et al. Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study. Cancer Causes Control 2012, 23:363-70. 10.1007/s10552-011-9885-6, 3261400, 22193397.
14. Bischoff-Ferrari HA, Giovannucci E, Willett WC, et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006, 84:18-28.
15. Forrest KY, Stuhldreher WL. Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res 2011, 31:48-54. 10.1016/j.nutres.2010.12.001, 21310306.
16. Giovannucci E. Vitamin D and cancer incidence in the Harvard cohorts. Ann Epidemiol 2009, 19:84-8. 10.1016/j.annepidem.2007.12.002, 18291673.
17. Klapdor S, Richter E, Klapdor R. Vitamin D status and per-oral vitamin D supplementation in patients suffering from chronic pancreatitis and pancreatic cancer disease. Anticancer Res 1991, 32:8.
18. Armstrong T, Strommer L, Ruiz-Jasbon F, et al. Pancreaticoduodenectomy for peri-ampullary neoplasia leads to specific micronutrient deficiencies. Pancreatology 2007, 7:37-44. 10.1159/000101876, 17449964.
19. Wortsman J, Matsuoka LY, Chen TC, et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000, 72:690-3.
20. Vimaleswaran KS, Berry DJ, Lu C, et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 2013, 10:e1001383. 10.1371/journal.pmed.1001383, 3564800, 23393431.
21. Wesa K, Cronin A, Segal NH, et al. Serum 25-hydroxy vimtain D (vit D) and surviavl in colorectal cancer (CRC): a retrospecitve analysis (abstract 3615). J Clin Oncol 2010, 28:289.
22. Newton-Bishop JA, Beswick S, Randerson-Moor J, et al. Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma. J Clin Oncol 2009, 27:5439-44. 10.1200/JCO.2009.22.1135, 2773226, 19770375.
23. Heist RS, Zhou W, Wang Z, et al. Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer. J Clin Oncol 2008, 26:5596-602. 10.1200/JCO.2008.18.0406, 2651100, 18936471.
24. Goodwin PJ, Ennis M, Pritchard KI, et al. Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol 2009, 27:3757-63. 10.1200/JCO.2008.20.0725, 19451439.
25. Piura ECJ, Lipoton A, et al. Serum 1-OH vitamin D adn prognosis of postmenopausal breast cancer patients: NCIC-CTG MA 14 trial. J Clin Oncol 2009, 27:534. suppl:Abstract.
26. Hama T, Norizoe C, Suga H, et al. Prognostic significance of vitamin D receptor polymorphisms in head and neck squamous cell carcinoma. PLoS One 2011, 6:e29634. 10.1371/journal.pone.0029634, 3248455, 22242137.
27. Innocenti F, Owzar K, Cox NL, et al. A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303. Clin Cancer Res 2012, 18:577-84. 10.1158/1078-0432.CCR-11-1387, 3412624, 22142827.